We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Effects of Repeated Psilocybin Dosing in OCD

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT05370911
Recruitment Status : Not yet recruiting
First Posted : May 12, 2022
Last Update Posted : November 23, 2022
Steven & Alexandra Cohen Foundation
Information provided by (Responsible Party):
Benjamin Kelmendi, MD, Yale University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : February 2026
Estimated Study Completion Date : February 2027